More
    Guided Solutions - Connecting Talent With Innovation/div>

    Novocure Announces Update on Phase 3 Pivotal LUNAR Trial

    International oncology company, Novocure, has announced an update regarding its phase 3 pivotal LUNAR trial of Tumor Treating Fields (TTFields) in stage 4 non-small cell lung cancer (NSCLC) following platinum failure. Following a...

    Novocure Announces Update on Phase 3 Pivotal LUNAR Trial

    International oncology company, Novocure, has announced an update regarding its phase 3 pivotal LUNAR trial of Tumor Treating Fields (TTFields) in stage 4...

    OncoSec Receives CE Mark Certification for its Commercial Electroporation Device “GenPulse™” for the Treatment of Solid Tumors

    CE mark enables commercialization of GenPulse™ in EU OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company"...

    Endologix acquires PQ Bypass to expand vascular product portfolio

    Deerfield Management owned Endologix has acquired medical technology company PQ Bypass to bolster vascular reach to treat unmet medical needs of both...

    CeQur raises $115M for wearable insulin delivery device

    CeQur announced that it closed an oversubscribed equity financing round with proceeds of $115 million.

    Get Weekly Newsletter

    Finance

    Novocure Announces Update on Phase 3 Pivotal LUNAR Trial

    International oncology company, Novocure, has announced an update regarding its phase 3 pivotal LUNAR trial of Tumor Treating Fields (TTFields) in stage 4...

    OncoSec Receives CE Mark Certification for its Commercial Electroporation Device “GenPulse™” for the Treatment of Solid Tumors

    CE mark enables commercialization of GenPulse™ in EU OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company"...

    Endologix acquires PQ Bypass to expand vascular product portfolio

    Deerfield Management owned Endologix has acquired medical technology company PQ Bypass to bolster vascular reach to treat unmet medical needs of both...

    CeQur raises $115M for wearable insulin delivery device

    CeQur announced that it closed an oversubscribed equity financing round with proceeds of $115 million.

    Funding

    CeQur raises $115M for wearable insulin delivery device

    CeQur announced that it closed an oversubscribed equity financing round with proceeds of $115 million.

    Cardiology robotics platform completes seed round of €4.7M with European Heal Capital

    The company will use the funding to develop remote user interaction for structural heart interventions.

    Memic Innovative Surgery Closes $96M Series D Financing

    Financing led by Peregrine Ventures and Ceros with participation from OurCrowd and Accelmed. Funding primarily supports the commercialisation of...

    Clinical Trials

    Novocure Announces Update on Phase 3 Pivotal LUNAR Trial

    International oncology company, Novocure, has announced an update regarding its phase 3 pivotal LUNAR trial of Tumor Treating Fields (TTFields) in stage 4...

    Fitbit begins smartwatch blood pressure tracking study

    Starting this month, eligible Fitbit Sense users can participate in the study, which will look into how pulse arrival time can be...

    UroMems Completes €23 Million Series B Financing

    Further participation from existing investors raised additional €7 million Additional capital to fund initiation of the first clinical trial...

    Pixium Puts Second Sight in Rear View with Pivotal Trial

    Pixium’s PRIMAvera study is an open-label, baseline-controlled, nonrandomized, multi-center, prospective, single-arm confirmatory trial of the Prima System. The implant is a bionic...
    1,663FollowersFollow

    Innovation

    First Clinical Use of Next-Gen Viseon MaxView for Minimally Invasive Oblique Lateral Lumbar Interbody Fusion

    Viseon announced the first clinical use of the next generation of the MaxView™ System for Oblique Lateral Interbody Fusion...

    New wearable aims to tackle head injuries in sport

    Wearable tech which measures and tracks head impact force in sport and recreational activities is set to aid research and support informed...

    LumiraDx to merge with CAHC in $5bn deal

    CA Healthcare Acquisition Corp.— a special purpose acquisition company — announced today that it entered a merger agreement with LumiraDx that will take the...

    Regulatory Approvals

    Novocure Announces Update on Phase 3 Pivotal LUNAR Trial

    International oncology company, Novocure, has announced an update regarding its phase 3 pivotal LUNAR trial of Tumor Treating Fields (TTFields) in stage 4...

    OncoSec Receives CE Mark Certification for its Commercial Electroporation Device “GenPulse™” for the Treatment of Solid Tumors

    CE mark enables commercialization of GenPulse™ in EU OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company"...

    Endologix acquires PQ Bypass to expand vascular product portfolio

    Deerfield Management owned Endologix has acquired medical technology company PQ Bypass to bolster vascular reach to treat unmet medical needs of both...

    CeQur raises $115M for wearable insulin delivery device

    CeQur announced that it closed an oversubscribed equity financing round with proceeds of $115 million.

    M&A

    Novocure Announces Update on Phase 3 Pivotal LUNAR Trial

    International oncology company, Novocure, has announced an update regarding its phase 3 pivotal LUNAR trial of Tumor Treating Fields (TTFields) in stage 4...

    OncoSec Receives CE Mark Certification for its Commercial Electroporation Device “GenPulse™” for the Treatment of Solid Tumors

    CE mark enables commercialization of GenPulse™ in EU OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company"...

    Endologix acquires PQ Bypass to expand vascular product portfolio

    Deerfield Management owned Endologix has acquired medical technology company PQ Bypass to bolster vascular reach to treat unmet medical needs of both...

    CeQur raises $115M for wearable insulin delivery device

    CeQur announced that it closed an oversubscribed equity financing round with proceeds of $115 million.

    Archives

    Latest articles

    Novocure Announces Update on Phase 3 Pivotal LUNAR Trial

    International oncology company, Novocure, has announced an update regarding its phase 3 pivotal LUNAR trial of Tumor Treating Fields (TTFields) in stage 4...

    OncoSec Receives CE Mark Certification for its Commercial Electroporation Device “GenPulse™” for the Treatment of Solid Tumors

    CE mark enables commercialization of GenPulse™ in EU OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company"...

    Endologix acquires PQ Bypass to expand vascular product portfolio

    Deerfield Management owned Endologix has acquired medical technology company PQ Bypass to bolster vascular reach to treat unmet medical needs of both...

    CeQur raises $115M for wearable insulin delivery device

    CeQur announced that it closed an oversubscribed equity financing round with proceeds of $115 million.

    First Clinical Use of Next-Gen Viseon MaxView for Minimally Invasive Oblique Lateral Lumbar Interbody Fusion

    Viseon announced the first clinical use of the next generation of the MaxView™ System for Oblique Lateral Interbody Fusion...

    Cardiology robotics platform completes seed round of €4.7M with European Heal Capital

    The company will use the funding to develop remote user interaction for structural heart interventions.

    Popular categories